ELAN FY 2023 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

FY 2023 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$4.4B+0.1% YoY

Gross Profit

$1.9B43.9% margin

Operating Income

$326M7.4% margin

Net Income

-$1.2B-27.9% margin

EPS (Diluted)

$-2.50

Cash Flow

Operating Cash Flow

$271M

Free Cash Flow

$117M

Stock-Based Comp.

$46M

Balance Sheet

Total Assets

$14.4B

Total Liabilities

$8.1B

Stockholders' Equity

$6.2B

Cash & Equivalents

$352M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$4.4B	$4.4B	+0.1%
Gross Profit	$1.9B	$2.0B	-1.6%
Operating Income	$326M	$384M	-15.1%
Net Income	-$1.2B	-$78M	-1478.2%